IMC Chicago’s ETRACS 2x Leveraged US Dividend Factor TR ETN SCDL Stock Holding History

IMC Chicago’s Portfolio SCDL Stock Details SCDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,499	Closed	-$271K	–	6730
2026 Q1	$271K	Buy	+5,499	New	+$262K	﹤0.01%	4710
2023 Q3	–	Sell	-10,173	Closed	-$315K	–	1640
2023 Q2	$315K	Sell	10,173 -2,218	-18%	-$66.2K	﹤0.01%	1242
2023 Q1	$388K	Sell	12,391 -280	-2%	-$9.18K	﹤0.01%	1211
2022 Q4	$427K	Buy	+12,671	New	+$409K	﹤0.01%	1159

Other funds holding SCDL

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

IMC Chicago's SCDL Position: Q2 2026 in Review

IMC Chicago sold out of ETRACS 2x Leveraged US Dividend Factor TR ETN (SCDL) in Q2 2026, closing a stake of 5,499 shares — an estimated $271K sold.

IMC Chicago first reported a position in SCDL in Q4 2022 and held it in 4 quarters. The position peaked at $427K in Q4 2022. 1 fund tracked by Wall St. Rank holds SCDL as of Q2 2026.

IMC Chicago reported no remaining ETRACS 2x Leveraged US Dividend Factor TR ETN position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 5,499 ETRACS 2x Leveraged US Dividend Factor TR ETN shares in Q2 2026, an estimated $271K.
IMC Chicago first reported a position in ETRACS 2x Leveraged US Dividend Factor TR ETN in Q4 2022 and held it in 4 quarters.
IMC Chicago's ETRACS 2x Leveraged US Dividend Factor TR ETN position peaked at $427K in Q4 2022.
1 fund tracked by Wall St. Rank held ETRACS 2x Leveraged US Dividend Factor TR ETN as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.